p53 and β-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma

Aida Ibricevic Richardson; C. Cameron Yin; Wei Cui; Nianyi Li; L. Jeffrey Medeiros; Linheng Li; Da Zhang

doi:10.1016/j.clml.2019.03.030

p53 and β-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma

Aida Ibricevic Richardson, C. Cameron Yin, Wei Cui, Nianyi Li, L. Jeffrey Medeiros, Linheng Li, Da Zhang

Hematopathology

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

p53 or β-catenin expression alone or β-catenin/p53 double expression showed poorer overall survival and disease-free survival in patients with anaplastic large-cell lymphoma (ALCL) overall and in patients with anaplastic lymphoma kinase–negative ALCL.

Original language	English (US)
Pages (from-to)	e385-e392
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	19
Issue number	7
DOIs	https://doi.org/10.1016/j.clml.2019.03.030
State	Published - Jul 2019

Keywords

ALCL
ALK
Survival
Wnt signaling
β-Catenin

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.clml.2019.03.030

Cite this

@article{b8a535c441f7407895b11e873c050763,

title = "p53 and β-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma",

abstract = "p53 or β-catenin expression alone or β-catenin/p53 double expression showed poorer overall survival and disease-free survival in patients with anaplastic large-cell lymphoma (ALCL) overall and in patients with anaplastic lymphoma kinase–negative ALCL.",

keywords = "ALCL, ALK, Survival, Wnt signaling, β-Catenin",

author = "Richardson, {Aida Ibricevic} and Yin, {C. Cameron} and Wei Cui and Nianyi Li and Medeiros, {L. Jeffrey} and Linheng Li and Da Zhang",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2019",

month = jul,

doi = "10.1016/j.clml.2019.03.030",

language = "English (US)",

volume = "19",

pages = "e385--e392",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Cancer Media Group",

number = "7",

}

TY - JOUR

T1 - p53 and β-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma

AU - Richardson, Aida Ibricevic

AU - Yin, C. Cameron

AU - Cui, Wei

AU - Li, Nianyi

AU - Medeiros, L. Jeffrey

AU - Li, Linheng

AU - Zhang, Da

PY - 2019/7

Y1 - 2019/7

N2 - p53 or β-catenin expression alone or β-catenin/p53 double expression showed poorer overall survival and disease-free survival in patients with anaplastic large-cell lymphoma (ALCL) overall and in patients with anaplastic lymphoma kinase–negative ALCL.

AB - p53 or β-catenin expression alone or β-catenin/p53 double expression showed poorer overall survival and disease-free survival in patients with anaplastic large-cell lymphoma (ALCL) overall and in patients with anaplastic lymphoma kinase–negative ALCL.

KW - ALCL

KW - ALK

KW - Survival

KW - Wnt signaling

KW - β-Catenin

UR - http://www.scopus.com/inward/record.url?scp=85065143505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065143505&partnerID=8YFLogxK

U2 - 10.1016/j.clml.2019.03.030

DO - 10.1016/j.clml.2019.03.030

M3 - Article

C2 - 31078446

AN - SCOPUS:85065143505

SN - 2152-2650

VL - 19

SP - e385-e392

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

IS - 7

ER -

p53 and β-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this